We Don't Need More Monkeys, We Need a New Strategy to Test Vaccines

The New York Times recently reported that research monkeys are “in short supply,” arguing that the U.S. needs to create a “strategic monkey reserve” to adequately respond to new strains of SARS-CoV-2 and future pandemics. 

Why Researchers Need to Stop Monkeying Around With Vaccine Development! - Blog - PETA India

CDC recommends new COVID boosters for all: But who will pay for it?

Labs scramble to find right animals for coronavirus studies - STAT

Monkeypox in Brazil between stigma, politics, and structural shortcomings: have we not been here before? - The Lancet Regional Health – Americas

How wild monkeys 'laundered' for science could undermine research

Monkeypox vaccine: FDA authorizes change in how vaccine is given, in order to stretch supply

Mice, hamsters, ferrets, monkeys. Which lab animals can help defeat the new coronavirus?, Science

COVID vaccine, treatment trials create monkey shortage for science

New evidence COVID-19 antibodies, vaccines less effective against variants – Washington University School of Medicine in St. Louis

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques: Molecular Therapy

A small number of monkeys could help millions of people: Coronavirus vaccine testing – Speaking of Research

US Primate Centers Work to Protect Animals from COVID-19

The U.S. Is Running Out of Research Monkeys - WSJ

Republican lawmaker's pro-vaccine messages are part of an effort to 'get the politics out of the vaccination process

COVID-19 Experiments on Animals: Facts, Alternatives